Policy-makers are being urged to take notice of a University of Otago study that confirms that undertaking a short program of high intensity interval training before surgery can substantially help with recovery.
Biogen and Ionis abandon ALS drug after disappointing early-stage trial
Biogen and Ionis are dropping an experimental treatment for amyotrophic lateral sclerosis, or ALS, a neurodegenerative disease in which people lose muscle control over time.